Kwang Dong Pharmaceutical Co., Ltd.
Research Kwang Dong Pharmaceutical Co., Ltd. (009290.KS) on Bullrun: market cap KRW 333.50B, dividend yield 1.5%. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- Ticker009290.KS
- ExchangeKS
- CountrySouth Korea
- SectorConsumer Defensive
- IndustryPackaged Foods
- CurrencyKRW
- Market capKRW 333.50B
- Dividend yield1.5%
- Financial periodQ2 2026
- RevenueKRW 439.82B
- Net incomeKRW 2.71B
- Free cash flow-KRW 15.63B
- Gross margin17.5%
Valuation Snapshot
latest market cap is KRW 333.50B; dividend yield is 1.5%.
Peer valuation comparison
Latest dividend yield is 1.49% versus a Consumer Defensive sector median of 2.98% (50.0% below).
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-11-11 | KRW 333.50B | n/a | 1.6% | 100 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 100 KRW, yield 1.5%.
About Kwang Dong Pharmaceutical Co., Ltd.
Kwang Dong Pharmaceutical Co., Ltd. operates as a human healthcare provider in South Korea. It develops and sells OTC drugs in the areas of ophthalmic, mineral preparations, nutritious tonics, antipyretic, analgesic, anti inflammatory agents, circulating system, and vitamins; and ETC drugs in the areas of anti-malignant-tumor agent, obesity drug, appetite suppressant, antipyretic, analgesic, anti-inflammatory agents, neuropsychiatric solvent, digestive organ agent, antibiotic, and vitamins.
ETFs that hold Kwang Dong Pharmaceutical Co., Ltd.
US-listed ETFs
Kwang Dong Pharmaceutical Co., Ltd. is held by 13 US-listed ETFs, going by the latest portfolios they filed with the SEC. The 8 most traded of them:
| ETF | Weight | Fee |
|---|---|---|
| Vanguard FTSE Developed Markets Index Fund ETF Shares (VEA) | <0.01% | 0.03% |
| Vanguard Total International Stock Index Fund ETF Shares (VXUS) | <0.01% | 0.05% |
| Vanguard Total World Stock Index Fund ETF Shares (VT) | <0.01% | 0.06% |
| Vanguard FTSE Pacific Index Fund ETF Shares (VPL) | <0.01% | 0.07% |
| Vanguard FTSE All-World ex-US Small-Cap Index Fund ETF Shares (VSS) | <0.01% | 0.06% |
| Dimensional Emerging Core Equity Market ETF (DFAE) | <0.01% | 0.29% |
| Dimensional Emerging Markets Core Equity 2 ETF (DFEM) | <0.01% | 0.39% |
| Dimensional World ex U.S. Core Equity 2 ETF (DFAX) | <0.01% | 0.28% |
Portfolios as filed with the SEC on Form N-PORT, dated June to July 2026. Brokers in the EU generally do not offer US-listed ETFs to retail investors.
Related stock research
Other Consumer Defensive stocks
Frequently asked questions
What is Kwang Dong Pharmaceutical Co., Ltd.'s market cap?
Kwang Dong Pharmaceutical Co., Ltd.'s market capitalization is KRW 333.50B.
Does Kwang Dong Pharmaceutical Co., Ltd. pay a dividend?
Kwang Dong Pharmaceutical Co., Ltd. has a dividend yield of 1.5%.
What does Kwang Dong Pharmaceutical Co., Ltd. do?
Kwang Dong Pharmaceutical Co., Ltd. operates as a human healthcare provider in South Korea. It develops and sells OTC drugs in the areas of ophthalmic, mineral preparations, nutritious tonics, antipyretic, analgesic, anti inflammatory agents, circulating system, and vitamins; and ETC drugs in the areas of anti-malignant-tumor agent, obesity drug, appetite suppressant, antipyretic, analgesic, anti-inflammatory agents, neuropsychiatric solvent, digestive organ agent, antibiotic, and vitamins.